This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FitzGerald, J. M.
Right arrow Articles by Elwood, R. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FitzGerald, J. M.
Right arrow Articles by Elwood, R. K.
Related Collections
Right arrow Socioeconomic determinants of health
Right arrow Aboriginal Health
Right arrow Vaccination
Right arrow Tuberculosis Series
CMAJ • February 8, 2000; 162 (3)
© 2000 Canadian Medical Association or its licensors


Review
Synthèse

Clinical Basics

Tuberculosis: 13. Control of the disease among aboriginal people in Canada

J. Mark FitzGerald, Lei Wang and R. Kevin Elwood

From the BC Centre for Disease Control Society, Vancouver, BC

Series editor: Dr. Anne Fanning

Abstract

Case 1: A 36-year-old aboriginal woman has a 12-mm-diameter reaction to a tuberculosis (TB) skin test, done as part of a community survey. She was vaccinated with BCG (bacille Calmette-Guérin) at 6 weeks of age. There is no documented history of contact with TB, and no skin tests were carried out previously. The woman's family doctor wonders about the significance of the result.

Case 2: A 27-year-old aboriginal man presents with a 6-week history of cough and fever and recent onset of hemoptysis. He has recently completed 2 courses of antibiotics, but there has been no improvement in symptoms. Chest radiography shows right upper lobe pneumonia. A further course of antibiotics is prescribed. What investigations should be completed next?

Case 3: The mother of a 2-day-old aboriginal infant asks for advice about the benefits of BCG vaccination. She is confused about the side effects of BCG and its effectiveness.





This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
K. Aissa, F. Madhi, N. Ronsin, F. Delarocque, A. Lecuyer, B. Decludt, N. Remus, L. Abel, C. Poirier, C. Delacourt, et al.
Evaluation of a Model for Efficient Screening of Tuberculosis Contact Subjects
Am. J. Respir. Crit. Care Med., May 1, 2008; 177(9): 1041 - 1047.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
M. Clark and E. Vynnycky
The use of maximum likelihood methods to estimate the risk of tuberculous infection and disease in a Canadian First Nations population
Int. J. Epidemiol., June 1, 2004; 33(3): 477 - 484.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. Nguyen, J.-F. Proulx, J. Westley, L. Thibert, S. Dery, and M. A. Behr
Tuberculosis in the Inuit Community of Quebec, Canada
Am. J. Respir. Crit. Care Med., December 1, 2003; 168(11): 1353 - 1357.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
M. Clark, P. Riben, and E. Nowgesic
The association of housing density, isolation and tuberculosis in Canadian First Nations communities
Int. J. Epidemiol., October 1, 2002; 31(5): 940 - 945.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
L Wang, M O Turner, R K Elwood, M Schulzer, and J M FitzGerald
A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements
Thorax, September 1, 2002; 57(9): 804 - 809.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
TB among aboriginal Canadians
Can. Med. Assoc. J., May 1, 2000; 162(10): 1404 - 1404.



Home page
CMAJHome page
Treating TB in the 1950s
Can. Med. Assoc. J., May 1, 2000; 162(10): 1405 - 1405.



Home page
CMAJHome page
TB among aboriginal Canadians
Can. Med. Assoc. J., May 1, 2000; 162(10): 1404 - 1405.